We have seen FRE (Firebrick) go straight into the US with a simple description of Nasodine being a nasal disinfectant, and no attempt to get FDA approval.
This article in Newsweek in the crucial mid 2021 shows what a hard time antiviral nasal sprays have had in the US, whilst there was an all out pursuit of VACCINES and Big Pharma was of course testing expensive Paxlovid.
So maybe Starpharma management is wise in not pursuing US authorities for EUS - FDA & CDC.
https://www.newsweek.com/nasal-spray-company-pushes-cdc-fda-accept-its-claims-help-treat-covid-1627712
This paragraph is particularly telling
"...The FDA also asked for a safety trial. But over-the-counter nasal sprays have been on the market for years with almost no serious safety concerns. "It just makes no sense," says a source familiar with the company's communications with the agency. ''They want mountains from us and a molehill from the drug makers."..."
- Forums
- ASX - By Stock
- SPL
- Could this happen to Viraleze with marketing approval
Could this happen to Viraleze with marketing approval, page-30
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
10.0¢ |
Change
0.002(2.04%) |
Mkt cap ! $41.73M |
Open | High | Low | Value | Volume |
9.9¢ | 10.5¢ | 9.9¢ | $49.15K | 486.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 65751 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 226460 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 65751 | 0.100 |
2 | 107649 | 0.099 |
1 | 300000 | 0.098 |
2 | 45155 | 0.097 |
2 | 100000 | 0.096 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 226460 | 3 |
0.110 | 240068 | 5 |
0.115 | 109827 | 3 |
0.120 | 63057 | 7 |
0.125 | 80424 | 5 |
Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |